Salicylate hydroxylation as an early marker of in vivo oxidative stress in diabetic patients.
In vivo metabolism of salicylic acid produces two main hydroxylated derivatives (2,5- and 2,3-dihydroxybenzoic acid). The former can be produced by enzymatic pathways through the cytochrome P-450 system, while the latter is reported to be solely formed by direct hydroxyl radical attack. Therefore, measurement of 2,3-dihydroxybenzoate, following oral administration of salicylate in its acetylated form (aspirin), has been proposed for assessment of oxidative stress. In this article we report plasma levels of 2,3- and 2,5-dihydroxybenzoates following the administration of 1 g aspirin and plasma levels of thiobarbituric acid-reactive material (TBARM) in well-controlled diabetic patients and in healthy subjects. 2,3-Dihydroxybenzoate levels were significantly higher (23%) in diabetic patients than in controls (63.4 +/- 20.1 versus 49.0 +/- 6.8 nM; p < .05). On the other hand, TBARM values were not significantly different between groups. These results suggest that the method is useful to reveal in vivo oxidative stress independently from the peroxidation of lipids, and they support the hypothesis that oxygen radicals are involved in the pathogenesis of chronic complications of diabetes.
Ghiselli
A
A
National Institute of Nutrition, Rome, Italy.
Laurenti
O
O
De Mattia
G
G
Maiani
G
G
Ferro-Luzzi
A
A
D000328:Adult; D001241:Aspirin / Q000378:metabolism*; D003922:Diabetes Mellitus, Type 1 / Q000097:blood*; D005260:Female; D005841:Gentisates; D006801:Humans; D062385:Hydroxybenzoates / Q000097:blood*; D006900:Hydroxylation; D008297:Male; D010084:Oxidation-Reduction; D017382:Reactive Oxygen Species / Q000378:metabolism; D012459:Salicylates / Q000097:blood; D013858:Thiobarbiturates
D005841:Gentisates; D062385:Hydroxybenzoates; D017382:Reactive Oxygen Species; D012459:Salicylates; D013858:Thiobarbiturates; C009135:2,3-dihydroxybenzoic acid; C029684:thiobarbituric acid; D001241:Aspirin; C010925:2,5-dihydroxybenzoic acid